Prevention of adverse effects in intravenous cholangiocystography. 2
Preuss, H.J.
Das Deutsche Gesundheitswesen 27(14): 647-650
1972
ISSN/ISBN: 0012-0219 PMID: 5036066 Document Number: 45715
Document emailed within 1 workday
Related Documents
Taenzer, V.; Rühl, U. 1971: Intravenous cholangiography: influence of contrast medium dosage on picture quality and adverse effects Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 115(6): 808-813Balslev, U.; Nielsen, T.L. 1992: Adverse effects associated with intravenous pentamidine isethionate as treatment of Pneumocystis carinii pneumonia in AIDS patients Danish Medical Bulletin 39(4): 366-368
Zimmerman, B.; Gold, R.; Lavi, S. 1987: Adverse effects of immunization. Is prevention possible? Postgraduate Medicine 82(5): 225-9 232
Janiec, W.; Pietryka, B.; Sliwiński, L.; Leszczyńska, J. 1985: Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids Wiadomosci Lekarskie 38(22): 1613-1619
2015: Subcutaneous trastuzumab (Herceptin). Ready to use, but more serious adverse effects than intravenous (IV) trastuzumab Prescrire International 24(159): 93
Stricker, B.H.; Ottervanger, J.P.; van der Klauw, M.M. 1994: Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993 Nederlands Tijdschrift Voor Geneeskunde 138(42): 2110-2113
Pavelka, K. 1985: Prevention of adverse side-effects of nonsteroidal antirheumatic agents Vnitrni Lekarstvi 31(7): 706-710
2011: Denosumab. Limited efficacy in fracture prevention, too many adverse effects Prescrire International 20(117): 145-148
Henneberg, M. 1979: Course: Drug information and prevention of adverse effects exerted by drugs Przeglad Lekarski 36(2): 291-292
Tarnow, J.; Hess, W. 1979: Flunitrazepam-pretreatment for prevention of adverse cardiovascular effects following ketamine Der Anaesthesist 28(10): 468-473
Gerdén, B. 2005: The Medical Products Agency about SSRi to pregnant women and adverse effects on the fetus. Long-term adverse effects are not proved, documentation is insufficient, more research is necessary Lakartidningen 102(10): 791
Janiec, W.; Pietryka, B.; Pytlik, M.; Leszczyńska, J. 1985: Adverse effects of non-steroidal anti-inflammatory drugs. II. Adverse effects of heterocyclic enols Wiadomosci Lekarskie 38(24): 1745-1750
Sepúlveda, B. 1970: Adverse effects of contraceptives. II. Adverse effects of contraceptive steroids on the liver Gaceta Medica de Mexico 100(8): 823-831
Kiyokawa, H. 1991: Strategies for prevention of adverse transfusion effects. Immediate and delayed transfusion effects: laboratory reference for transfusion reactions Rinsho Byori. Japanese Journal of Clinical Pathology Suppl. 88: 128-137
Carpintero, D.J. 1983: Use of thioctic acid for prevention of the adverse effects induced by benznidazole in patients with chronic Chagas' infection Medicina 43(3): 285-290
Cherenkov, V.G.; Petrov, A.B.; Shpenkova, A.A.; Vasil'eva, T.M. 2012: Use of Reamberin for the prevention of adverse effects of combined antineoplastic agents in stage III-IV ovarian cancer during induction treatment Voprosy Onkologii 58(1): 110-114
Lobachik, V.I.; Gordeev, I.V.; Nosovskiĭ, A.M.; Pishchulina, G.N.; Chupushtanov, S.A.; Krotov, V.P. 2004: Prevention of the adverse effects of head-down tilting on the infrastructure of body fluids and postural stability of primates by exposure to g-loads Aviakosmicheskaia i Ekologicheskaia Meditsina 38(3): 27-29
Swiderski, R.; Bak-Dzierzyński, A.; Piróg, L.; Zdebski, Z.; Niespodziański, K. 1978: Analysis of the effects of prevention of threatened abortion and premature labor with intravenous and oral preparation, Partusisten Ginekologia Polska 49(7): 621-624
Gram, L.F. 1977: Adverse effects during treatment with beta receptor blockaders. Report from the Adverse Drug Reaction Committee 1968-1976 Ugeskrift for Laeger 139(35): 2065-2068
Tomori, Z. 1981: The adverse effects of smoking and methods of smoking prevention Bratislavske Lekarske Listy 76(3): 374-382